Last 48 quarters of trend data · Basic Materials · Chemicals - Specialty
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Balchem Corporation's quarterly P/E stands at 33.9x, down 7.7% year-over-year. EV/EBITDA has expanded 8.1% YoY to 24.4x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 33.58 | 33.90 | 31.69 | 30.25 | 34.02 | 36.73 | 39.56 | 42.72 | 39.27 | 43.53 | 45.35 | 34.46 | 36.24 |
| — | -7.7% | -19.9% | -29.2% | -13.4% | -15.6% | -12.8% | +24.0% | +8.4% | -3.6% | -2.0% | -11.6% | +2.8% | |
| P/S Ratio | 4.92 | 5.05 | 4.70 | 4.59 | 5.10 | 5.43 | 5.53 | 6.01 | 5.37 | 5.27 | 5.28 | 4.38 | 4.73 |
| — | -7.0% | -14.9% | -23.7% | -5.0% | +3.1% | +4.6% | +37.3% | +13.6% | +19.6% | +24.2% | +8.7% | +6.7% | |
| P/B Ratio | 4.14 | 4.26 | 3.94 | 3.78 | 4.11 | 4.51 | 4.61 | 4.90 | 4.52 | 4.69 | 4.58 | 3.93 | 4.34 |
| — | -5.5% | -14.6% | -22.9% | -9.0% | -3.9% | +0.7% | +24.7% | +4.1% | +11.3% | +8.7% | -10.5% | -6.6% | |
| P/FCF | 29.51 | 34.14 | 24.27 | 24.21 | 32.23 | 44.06 | 33.50 | 34.22 | 32.97 | 47.73 | 21.63 | 26.39 | 40.85 |
| — | -22.5% | -27.6% | -29.2% | -2.3% | -7.7% | +54.9% | +29.7% | -19.3% | +17.0% | -40.6% | -28.6% | +46.9% | |
| EV / EBITDA | 19.83 | 24.41 | 17.79 | 16.28 | 21.30 | 22.59 | 23.41 | 25.22 | 22.51 | 24.02 | 24.32 | 18.94 | 21.02 |
| — | +8.1% | -24.0% | -35.4% | -5.3% | -6.0% | -3.7% | +33.1% | +7.1% | +2.8% | +5.5% | -17.0% | -4.5% | |
| EV / EBIT | 23.93 | — | 24.29 | 23.05 | 25.86 | 27.54 | 28.88 | 30.97 | 28.86 | 31.46 | 33.05 | 25.26 | 27.15 |
| — | — | -15.9% | -25.6% | -10.4% | -12.4% | -12.6% | +22.6% | +6.3% | -2.8% | -6.1% | -19.4% | -4.3% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Balchem Corporation's operating margin was 20.5% in Q1 2026, down 2.2 pp QoQ and up 0.2 pp YoY. Gross margin expanded 6.1% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.7% | 37.3% | 35.6% | 35.7% | 36.4% | 35.2% | 36.0% | 35.6% | 35.5% | 34.0% | 32.8% | 33.3% | 33.4% |
| — | +6.1% | -1.0% | +0.3% | +2.8% | +3.5% | +9.7% | +6.9% | +6.0% | +8.1% | +11.1% | +18.8% | +10.1% | |
| Operating Margin | 21.1% | 20.5% | 22.8% | 20.4% | 20.1% | 20.4% | 19.8% | 20.0% | 19.6% | 17.4% | 16.8% | 19.0% | 18.5% |
| — | +0.9% | +15.3% | +2.0% | +2.9% | +17.1% | +17.9% | +5.5% | +5.6% | +17.5% | +17.0% | +37.8% | +9.8% | |
| Net Margin | 14.9% | 14.9% | 14.9% | 15.1% | 15.0% | 14.8% | 14.0% | 14.1% | 13.7% | 12.1% | 11.7% | 12.6% | 13.0% |
| — | +0.6% | +6.3% | +6.8% | +9.4% | +22.3% | +20.1% | +11.5% | +5.2% | +23.8% | +26.6% | +22.3% | +3.5% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 12.9% | 3.2% | 3.1% | 3.1% | 3.1% | 3.1% | 2.9% | 3.0% | 2.9% | 2.7% | 2.6% | 2.9% | 3.0% |
| — | +0.9% | +6.4% | +6.3% | +5.6% | +15.6% | +12.6% | +3.3% | -3.7% | +14.4% | +9.8% | +1.8% | -9.4% | |
| ROA | 9.4% | 2.4% | 2.3% | 2.4% | 2.3% | 2.3% | 2.1% | 2.1% | 2.0% | 1.8% | 1.7% | 1.8% | 1.9% |
| — | +2.1% | +10.0% | +13.1% | +14.6% | +27.6% | +27.2% | +18.2% | +9.3% | +30.3% | +26.7% | +15.8% | -12.8% | |
| ROIC | 12.2% | 3.2% | 3.2% | 2.9% | 2.8% | 2.9% | 2.7% | 2.7% | 2.6% | 2.4% | 2.2% | 2.4% | 2.4% |
| — | +11.3% | +21.0% | +8.4% | +8.2% | +21.7% | +24.3% | +11.2% | +9.1% | +22.7% | +14.3% | +23.7% | -12.7% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Balchem Corporation's Debt/EBITDA ratio is 0.6x, down from 2.7x last quarter — comfortably within a safe range.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.15 | 0.03 | 0.15 | 0.13 | 0.16 | 0.17 | 0.18 | 0.21 | 0.26 | 0.30 | 0.31 | 0.39 | 0.42 |
| — | -84.8% | -15.6% | -36.4% | -36.3% | -42.2% | -42.3% | -46.5% | -39.1% | -35.5% | -36.2% | -26.7% | -14.9% | |
| Debt / EBITDA | 0.73 | 0.61 | 2.69 | 2.23 | 3.30 | 3.35 | 3.57 | 4.16 | 4.90 | 5.81 | 6.31 | 6.96 | 7.55 |
| — | -81.9% | -24.5% | -46.4% | -32.6% | -42.3% | -43.4% | -40.2% | -35.1% | -38.0% | -35.4% | -30.3% | -12.3% | |
| Current Ratio | 2.07 | 2.55 | 2.07 | 2.72 | 2.64 | 2.44 | 1.99 | 2.98 | 2.83 | 2.61 | 2.12 | 3.16 | 2.94 |
| — | +4.6% | +4.2% | -8.7% | -6.5% | -6.6% | -6.0% | -5.7% | -4.0% | -9.3% | -11.7% | +21.9% | +12.4% | |
| Quick Ratio | 1.33 | 1.59 | 1.33 | 1.67 | 1.57 | 1.40 | 1.16 | 1.90 | 1.79 | 1.72 | 1.38 | 2.08 | 1.85 |
| — | +13.4% | +14.4% | -11.8% | -12.5% | -18.8% | -15.8% | -8.9% | -3.1% | -4.7% | -10.7% | +29.3% | +12.8% | |
| Interest Coverage | 20.48 | 17.92 | 23.97 | 23.14 | 18.72 | 17.40 | 16.78 | 11.78 | 10.72 | 7.83 | 7.29 | 6.53 | 8.44 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying BCPC stock.
Balchem Corporation's current P/E is 33.6x. The average P/E over the last 4 quarters is 32.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Balchem Corporation's current operating margin is 21.1%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Balchem Corporation's business trajectory between earnings reports.